These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20214321)

  • 1. Identifying broadly neutralizing antibody activity in HIV-infected individuals.
    Kresge KJ
    IAVI Rep; 2009; 13(3):18. PubMed ID: 20214321
    [No Abstract]   [Full Text] [Related]  

  • 2. Study describes onset of broadly neutralizing antibody responses in HIV-infected individuals.
    von Bubnoff A
    IAVI Rep; 2011; 15(1):23. PubMed ID: 21449508
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificities of broadly neutralizing anti-HIV-1 sera.
    Binley J
    Curr Opin HIV AIDS; 2009 Sep; 4(5):364-72. PubMed ID: 20048699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Researchers make immunogen that can bind to precursors of broadly neutralizing antibodies.
    von Bubnoff A
    IAVI Rep; 2011; 15(5):22-3. PubMed ID: 22121551
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies: beyond neutralization.
    von Bubnoff A
    IAVI Rep; 2010; 14(1):8-12. PubMed ID: 20349583
    [No Abstract]   [Full Text] [Related]  

  • 6. New center focuses on neutralizing antibodies.
    McEnery R
    IAVI Rep; 2008; 12(5):15. PubMed ID: 20210066
    [No Abstract]   [Full Text] [Related]  

  • 7. Current world literature.
    Curr Opin HIV AIDS; 2009 Sep; 4(5):453-7. PubMed ID: 20046137
    [No Abstract]   [Full Text] [Related]  

  • 8. What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?
    Jülg B; Goebel FD
    Infection; 2005 Oct; 33(5-6):405-7. PubMed ID: 16258878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing antibodies bind HIV mostly with just one arm.
    von Bubnoff A
    IAVI Rep; 2009; 13(3):18-9. PubMed ID: 20217953
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early damage to the gut environment B cells need to mature.
    von Bubnoff A
    IAVI Rep; 2009; 13(4):20. PubMed ID: 20225579
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges for structure-based HIV vaccine design.
    Schief WR; Ban YE; Stamatatos L
    Curr Opin HIV AIDS; 2009 Sep; 4(5):431-40. PubMed ID: 20048708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding to the armamentarium of broadly neutralizing antibodies.
    von Bubnoff A
    IAVI Rep; 2010; 14(1):21. PubMed ID: 20349585
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevent and conquer.
    Kresge KJ; Jefferys R
    IAVI Rep; 2010; 14(1):13-20. PubMed ID: 20349584
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
    Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
    Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.
    Center RJ; Wheatley AK; Campbell SM; Gaeguta AJ; Peut V; Alcantara S; Siebentritt C; Kent SJ; Purcell DF
    Vaccine; 2009 Nov; 27(47):6605-12. PubMed ID: 19712773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IAVI opens AIDS vaccine laboratory in New York City. Newspaper Article.
    Kresge KJ
    IAVI Rep; 2008; 12(6):22. PubMed ID: 20218021
    [No Abstract]   [Full Text] [Related]  

  • 18. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of neutralizing antibodies in HIV infection.
    Humbert M; Dietrich U
    AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site.
    Chamat S; Nara P; Berquist L; Whalley A; Morrow WJ; Köhler H; Kang CY
    J Immunol; 1992 Jul; 149(2):649-54. PubMed ID: 1378074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.